These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 14411188)

  • 1. Further experiments on the carcinostatic action of bis(2-hydroxy-3,5-dibromophenylazo)-N-propylphloroglucinol.
    KOSHIMURA S; MURASAWA K; HIRATA R; BANDO Y
    Acta Unio Int Contra Cancrum; 1959; 15(Suppl 1)():154-8. PubMed ID: 14411188
    [No Abstract]   [Full Text] [Related]  

  • 2. Further experiments on the carcinostatic action of bis (2-hydroxy-3,5-dibromophenylazo)-propylphloroglucinol.
    KOSHIMURA S; HIRATA R; MURASAWA K; BANDO Y; MASUSAKI T; OHTA T; ISHIKAWA M
    Gan; 1957 Dec; 48(4):439-40. PubMed ID: 13524443
    [No Abstract]   [Full Text] [Related]  

  • 3. Carcinostatic activity of some dicarbonyl compounds and their bis-hydrazones.
    FRENCH FA; FREEDLANDER BL; HOSKING A; FRENCH J
    Acta Unio Int Contra Cancrum; 1960; 16():614-24. PubMed ID: 13824858
    [No Abstract]   [Full Text] [Related]  

  • 4. Production of metastases by treatment with carcinostatic agents. I. Effects of carcinostatic agents on the host.
    KONDO T; MOORE GE
    Cancer Res; 1961 Nov; 21():1396-9. PubMed ID: 14458172
    [No Abstract]   [Full Text] [Related]  

  • 5. Potentiation of the carcinostatic action of azauridine by chloramphenicol.
    CARDOSO SS; JAFFE JJ
    Biochem Pharmacol; 1961 Sep; 8():252-5. PubMed ID: 13876529
    [No Abstract]   [Full Text] [Related]  

  • 6. Structure and carcinostatic activity of certain ethylenephosphoramides. II. Alkyl and aralkyl diethylenephosphoramides.
    CROSSLEY ML; KUH E; ALLISON JB
    Cancer Res; 1962 Jun; 22():549-55. PubMed ID: 13882394
    [No Abstract]   [Full Text] [Related]  

  • 7. A new carcinostatic agent for the Ehrlich ascites tumor.
    FURST A; MILLER J; GROSS H; CUTTING W
    Acta Unio Int Contra Cancrum; 1960; 16():625-7. PubMed ID: 13825720
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of carcinostatic compounds on carbohydrate metabolism of tumor cells.
    SCHMIDT CG
    Acta Unio Int Contra Cancrum; 1962; 18():240-3. PubMed ID: 14498693
    [No Abstract]   [Full Text] [Related]  

  • 9. The carcinostatic effects of some plant components and their related compounds.
    HANO K
    Acta Unio Int Contra Cancrum; 1959; 15(Suppl 1)():122. PubMed ID: 14399557
    [No Abstract]   [Full Text] [Related]  

  • 10. Carcinostatic liver factor. I. Effect in vitro of homologous liver extracts on viability of Ehrlich ascites carcinoma cells.
    NAKAHARA W; FUKUOKA F
    Gan; 1961 Jun; 52():197-202. PubMed ID: 13727585
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-tumor and anti-invasive effects of diverse delta-alkyllactones: dependence on molecular side-chain length, action period and intracellular uptake.
    Tanaka H; Kageyama K; Yoshimura N; Asada R; Kusumoto K; Miwa N
    Life Sci; 2007 Apr; 80(20):1851-5. PubMed ID: 17382354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of carcinostatic compounds on the concentration of diphosphopyridine nucleotide in tumors].
    KROEGER H; ULRICH B; HOLZER H
    Arzneimittelforschung; 1959 Oct; 9():598-600. PubMed ID: 14412094
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the carcinostatic effect of 6-azauracil and of its ribosides. Studies on the effect of 6-azauracil and of its ribosides on the activity of normal tissues].
    HABERMANN V
    Cesk Fysiol; 1959 Jul; 8():326-7. PubMed ID: 13830676
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhancement of carcinostatic activity of omega-hydroxy fatty acids by their esterification through increased uptake into tumor cells.
    Kusumoto K; Kageyama K; Tanaka H; Kogawa H; Miwa N
    Oncol Rep; 2004 Apr; 11(4):857-61. PubMed ID: 15010885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On the influence of carcinostatic agents on the DPN metabolism of tumors. II. Detection of DPN constituents in ascites cells].
    KROEGER H; ROTTHAUWE HW; ULRICH B; HOLZER H
    Biochem Z; 1960; 333():155-65. PubMed ID: 13754445
    [No Abstract]   [Full Text] [Related]  

  • 16. [In vitro studies on the action of the cytostatic drug 2,5-bis-N-propyl-3,6-bis-ethylenimino-1,4-benzoquinone on bacteria].
    KREBS D
    Arzneimittelforschung; 1962 Jun; 12():588-90. PubMed ID: 14459502
    [No Abstract]   [Full Text] [Related]  

  • 17. Production of metastases by treatment with carcinostatic agents. 3. Low concentration of carcinostatic agents on the cells.
    Kondo T; Ichihashi H; Shizu Y; Momoi Y; Kawashima Y
    Nagoya J Med Sci; 1973 Nov; 36(1):1-10. PubMed ID: 4780531
    [No Abstract]   [Full Text] [Related]  

  • 18. [Leukopenia-inducing action of carcinostatic methansulfonic acid esters of aminoglycols, No. 838 and No. 864].
    Sakurai Y; Aoshima M
    Yakugaku Zasshi; 1970 Dec; 90(12):1556-62. PubMed ID: 5531683
    [No Abstract]   [Full Text] [Related]  

  • 19. Carcinostatic action of polycarbonyl compounds and their derivatives. II. Glyoxal bis (guanylhydrazone) and derivatives.
    FREEDLANDER BL; FRENCH FA
    Cancer Res; 1958 Apr; 18(3):360-3. PubMed ID: 13523604
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the influence of carcinostatic agents on the DPN metabolism of tumors. I. Incorporation of C-14-ribose and C-14-nicotinamide into the DPN of ascites cells].
    KROEGER H; ROTTHAUWE HW; ULRICH B; HOLZER H
    Biochem Z; 1960; 333():148-54. PubMed ID: 13754444
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.